Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CDKN2A Polymorphism in Melanoma Patients in Colombian Population: A Case-Control Study.

BioMed research international - 1 Jan 2020

Tovar-Parra Jose D, Gutiérrez-Castañeda Luz D, Gil-Quiñones Sebastián R, Nova Jhon A, Pulido Leonardo

Abstract excerpt

INTRODUCTION: Melanoma is the most aggressive type of skin cancer, with poor prognosis in advanced stages. The incidence and mortality rates have increased in recent years. Single nucleotide polymorphisms p.R24P, p.M53I, p.G101W, p.V126D, and p.A148T in the CDKN2A (HGNC ID: 1787) gene have been associated with the development of melanoma in different populations; however, this association has not been studied in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Colombia
Share to Cyclin-Dependent Kinase Inhibitor p16

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genes, p16

Share to Genetics, Population

Share to Homozygote

Share to Melanoma

Share to Skin Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 33102592
DOI: 10.1155/2020/7458917
PMCID: PMC7576359

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CDKN2A Polymorphism in Melanoma Patients in Colombian Population: A Case-Control Study.PMID 33102592Read ↗

3'UTR-CDKN2A and CDK4 Germline Variants Are Associated With Susceptibility to Cutaneous Melanoma.Semantic proximity Read ↗

CDKN2A/CDK4 status in Brazilian patients meeting clinical criteria for hereditary melanoma: a cross-sectional descriptive trial.Semantic proximity Read ↗

Association between VDR Gene Polymorphisms and Melanoma Susceptibility in a Colombian Population.Semantic proximity Read ↗

Germline CDKN2A mutations in Brazilian patients of hereditary cutaneous melanoma.Semantic proximity Read ↗

Characterization of individuals at high risk of developing melanoma in Latin America: bases for genetic counseling in melanoma.Semantic proximity Read ↗

Melanoma genetics: an update on risk-associated genes.Semantic proximity Read ↗

SLC45A2 Germilne Variants in Colombian Population with MelanomaSemantic proximity Read ↗

Epidemiological description of genetic alterations and prognosis in Mexican patients with melanoma: a retrospective cohort.Semantic proximity Read ↗

Drivers of melanoma susceptibilitySemantic proximity Read ↗

Mutations in the BRAF, NRAS, and C-KIT Genes of Patients Diagnosed with Melanoma in Colombia Population.Semantic proximity Read ↗

Genetic characterization of suspected hereditary melanoma in a Central Italy cohortSemantic proximity Read ↗

Novel CDKN2A mutations in Austrian melanoma patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.